| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| PCI domain containing 2 (PCID2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426705 | 100 ug | ORIGENE TECHNOLOGIES |
| PCI domain containing 2 (PCID2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY413085 | 100 ug | ORIGENE TECHNOLOGIES |
| PCIF1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403430 | 1 kit | ORIGENE TECHNOLOGIES |
| Catenin, beta interacting protein 1 (CTNNBIP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423325 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin, beta like 1 (CTNNBL1) from ORIGENE TECHNOLOGIES | LY403090 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), alpha 2 (CTNNA2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418015 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), alpha 3 (CTNNA3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415700 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), alpha 3 (CTNNA3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426767 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), alpha 1, 102kDa (CTNNA1) from ORIGENE TECHNOLOGIES | LY400708 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), alpha-like 1 (CTNNAL1) from ORIGENE TECHNOLOGIES | LY418424 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419662 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420557 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426005 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY420558 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426006 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421307 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 11 from ORIGENE TECHNOLOGIES | LY421316 | 100 ug | ORIGENE TECHNOLOGIES |
| Catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 5 from ORIGENE TECHNOLOGIES | LY421310 | 100 ug | ORIGENE TECHNOLOGIES |
| Cat eye syndrome chromosome region, candidate 1 (CECR1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413782 | 100 ug | ORIGENE TECHNOLOGIES |
| Cat eye syndrome chromosome region, candidate 1 (CECR1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406155 | 100 ug | ORIGENE TECHNOLOGIES |
| Cat eye syndrome chromosome region, candidate 1 (CECR1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430461 | 100 ug | ORIGENE TECHNOLOGIES |
| Cat eye syndrome chromosome region, candidate 5 (CECR5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413514 | 100 ug | ORIGENE TECHNOLOGIES |
| Cat eye syndrome chromosome region, candidate 5 (CECR5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409750 | 100 ug | ORIGENE TECHNOLOGIES |
| Cat eye syndrome chromosome region, candidate 6 (CECR6), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410458 | 100 ug | ORIGENE TECHNOLOGIES |
| Cathelicidin antimicrobial peptide (CAMP) from ORIGENE TECHNOLOGIES | LY401385 | 100 ug | ORIGENE TECHNOLOGIES |
| Cathepsin A (CTSA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424807 | 100 ug | ORIGENE TECHNOLOGIES |
| Cathepsin A (CTSA), transcript variant 3 from ORIGENE TECHNOLOGIES | LY433152 | 100 ug | ORIGENE TECHNOLOGIES |
| Cathepsin B (CTSB), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419666 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Artery: carotid; Atherosclerotic plaque from ORIGENE TECHNOLOGIES | CS646640 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: carotid; Paraganglioma of carotid body from ORIGENE TECHNOLOGIES | CS510493 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery, normal (protein lysate) from ORIGENE TECHNOLOGIES | CP565755 | 150 ug | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Aneurysm from ORIGENE TECHNOLOGIES | CS508866 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Aneurysm from ORIGENE TECHNOLOGIES | CS508867 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Aneurysm from ORIGENE TECHNOLOGIES | CS508868 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Arteriosclerosis from ORIGENE TECHNOLOGIES | CS810476 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS700296 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS802753 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS802754 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS807052 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS807053 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS807054 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS807298 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS807396 | 5x5um | ORIGENE TECHNOLOGIES |
| Cyclin D3 (CCND3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400666 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 2 associated protein 1 (CDK2AP1) from ORIGENE TECHNOLOGIES | LY401472 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 2 associated protein 2 (CDK2AP2) from ORIGENE TECHNOLOGIES | LY417039 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 14 (CDK14) from ORIGENE TECHNOLOGIES | LY415792 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 15 (CDK15) from ORIGENE TECHNOLOGIES | LY408389 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 19 (CDK19) from ORIGENE TECHNOLOGIES | LY414814 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 3 (CDK3) from ORIGENE TECHNOLOGIES | LY420045 | 100 ug | ORIGENE TECHNOLOGIES |